CNCNYSEHospital & Medical Service PlansFiscal year ends December 31
CENTENE CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026
$68.63−0.53 (-0.77%)
Close on Oct 19, 2026
- Market cap
- $34.15B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$33.36 (+94.58%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
CENTENE CORP grew revenue 13.9% to $202.94B over the twelve months to Jun 30, 2026. Operating income fell 394.4% to -$5.64B, moving the operating margin from 1.1% to -2.8%. Free cash flow was $8.95B, up 728.8% from a year earlier.
Revenue
$202.94B
+13.9% vs. a year earlier
Operating income
-$5.64B
-394.4% vs. a year earlier
Free cash flow
$8.95B
+728.8% vs. a year earlier
EPS, diluted
-$10.44
-358.4% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $34.15B
- P/E ratio
- –
- Price to sales
- 0.17
- Price to book
- 1.51
- Dividend yield
- –
- Free cash flow yield
- 26.21%
Fundamentals
- Revenue
- $202.94B
- Net income
- -$5.10B
- EPS, diluted
- -$10.44
- Free cash flow
- $8.95B
- Book value per share
- $45.34
- Diluted shares
- 498M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$202.94B+13.9% YoY
Gross profit
$16.17B+0.4% YoY
Operating income
-$5.64B-394.4% YoY
Net income
-$5.10B-348.3% YoY
EPS, diluted
-$10.44-358.4% YoY
Free cash flow
$8.95B+728.8% YoY
Reported periodTrailing twelve months